logo

For the Inventor, By the Inventor

Berlin, Germany

Bayer Schering Pharma Ag


USPTO Granted Patents = 192



Trademarks = 20

Forward Citations = 1,395

Loading Chart...
Loading Chart...

484 inventors (with patents filed for the assignee):

goldMedal Sabine Leifeld (24 out of 28 patents)

silverMedal Heike Ranze (23 out of 24 patents)

bronzeMedal Parviz Bazargani (23 out of 23 patents)

4.  Karl-Heinz Schlemmer (12 out of 120 patents)

5.  Michael Wiklund (12 out of 20 patents)

6.  Markus Berger (10 out of 37 patents)

7.  Hartmut Rehwinkel (10 out of 53 patents)

8.  Werner Skuballa (10 out of 106 patents)

9.  Dieter Lang (9 out of 67 patents)

10.  Karl-Heinz Thierauch (9 out of 29 patents)

11.  Ilkka Jutila (8 out of 25 patents)

12.  Wolfgang Schwede (8 out of 41 patents)

13.  Stuart Ince (8 out of 15 patents)

14.  Olaf Prien (8 out of 14 patents)

15.  Elisabeth Perzborn (8 out of 101 patents)


Core Competencies:
Tumor Vasculature
Contraception Composition
Metal Chelates
Quinolone Antibiotics
Capsaicin Receptor Proteins
Progesterone Receptor Antagonists
Kinase Inhibitors
Antiviral Agents
Pharmaceutical Compositions
Cell Differentiation Inducers
Optically Active Compounds
Dihydropyridines

192 patents:

1. 8680117 - [object Object] (2014-03-25),
2. 8491906 - Selective targeting of tumor vasculature using antibody molecules (2013-07-23),
3. RE44159 - Composition for contraception (2013-04-15),
4. RE43916 - Composition for contraception (2013-01-07),
5. 8263040 - Metal chelates having a perfluorinated PEG radical, processes for their preparation, and their use (2012-09-11),
6. D665163 - Display screen for a pill dispenser (2012-08-14),
7. D665162 - Display screen for a pill dispenser (2012-08-14),
8. D665161 - Display screen for a pill dispenser (2012-08-14),
9. 8227598 - Heteroaryl carboxamides (2012-07-24),
10. 8211930 - Phenyl and benzodioxinyl substituted indazoles derivatives (2012-07-03),
11. 8188270 - Polymorphous form of 5-chloro-N-({(5S)-2-oxo-3[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidine-5-yl}-methyl)-2-thiophene carboxamide (2012-05-29),
12. 8187632 - Sustained-release preparations of quinolone antibiotics (2012-05-29),
13. D657550 - Portion of a display screen for a pill dispenser (2012-04-17),
14. D657549 - Portion of a display screen for a pill dispenser (2012-04-17),
15. D657548 - Portion of a display screen for a pill dispenser (2012-04-17),
Bayer Schering Pharma AG is a leading global pharmaceutical company specializing in research, development, and production of innovative healthcare products. With a focus on improving lives and providing solutions, Bayer Schering Pharma AG aims to address the needs of patients and healthcare professionals worldwide. They offer a wide range of prescription and over-the-counter medications, focusing on therapeutic areas such as cardiovascular health, women's health, oncology, and radiology. With a commitment to scientific excellence and sustainable development, Bayer Schering Pharma AG is dedicated to advancing healthcare and making a positive impact on communities around the world.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

...
192 Patents

#8 in D-1000 Berlin

#349 in Germany

#4,261 in the World

...
Berlin, Germany

Bayer Schering Pharma Ag

Forward Citations = 1,395

484 inventors:

goldMedal Sabine Leifeld (24 out of 28 patents)

silverMedal Heike Ranze (23 out of 24 patents)

bronzeMedal Parviz Bazargani (23 out of 23 patents)

4.  Karl-Heinz Schlemmer (12 out of 120 patents)

5.  Michael Wiklund (12 out of 20 patents)

Please report any incorrect information to support@idiyas.com
Loading…